Callio therapeutics

Index
Globenewswire

Callio Therapeutics Wins Best New ADC Drug Developer at the 13th World ADC Awards, Presents Across Five Sessions at World ADC San Diego

Globenewswire

Callio Therapeutics Appoints Chris Hassig, PhD, as Chief Scientific Officer

Globenewswire

Callio Therapeutics Appoints Zachary Hornby as Chief Executive Officer

Globenewswire

Callio Therapeutics to Present Phase 1 Trial Design of CLIO-8221, Novel Dual-Payload ADC, at ASCO 2026